Birth Tissue Recovery Service Provider

listing image
Gross Revenue:$3,201,000
EBITDA:$1,036,000
BUSINESS DESCRIPTION

The Company is an industry leader in the development of human birth tissue donation programs. The Company partners with hospitals and physicians offices to provide human birth tissues for regenerative medicine, manufacturing of placental tissue allografts, and other innovative biologic wound care products.

Key Aspects
·Total revenue growth has increased by an impressive 79% from 2021 through the trailing twelve month (TTM) period ending July 31, 2024.
· The Company has established dependable partnerships with tissue banks, which have facilitated scalable business growth and supported organic expansion.
· The Company has distinguished itself in the industry by prioritizing the quality of tissue recovery, the accuracy and completeness of donor charts, and the timely delivery of tissue to end users.
· All contracts with tissue processors are recurring, and the Company's exceptional service has resulted in a high rate of repeat business.
· Financials as of 7/24
REF-BN000055457


DETAILED INFORMATION
Inventory
Not Included in asking price
Real Estate
Leased
Growth & Expansion
· Explore marketing opportunities directly with physician groups, which may have more bandwidth than hospitals. · Expand and establish new donor-generating relationships with labor and delivery hospitals. · Leverage the rapid growth in medical costs and the increasing demand for innovative regenerative healthcare treatments that are capturing significant attention within the industry.
Report an Issue with this listing
Matthew Kekelis
logo-img
Matthew Kekelis